Sequential usage of imidazole followed by tamoxifen to enhance the anticancer effect of tamoxifen in estrogen receptor-positive breast cancer cell lines.

被引：2
|
作者：
Inci, Tarik
Kahraman, Erkan
Goker, Erdem
机构：
[1] Ege Univ Hosp, Izmir, Turkey
[2] Ege Univ, Ataturk Hlth Care Vocat Sch, Izmir, Turkey
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.e15057
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15057
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Role of SALL4 and Nodal in the prognosis and tamoxifen resistance of estrogen receptor-positive breast cancer
    Boustan, Arad
    Mosaffa, Fatemeh
    Jahangiri, Rosa
    Heidarian-Miri, Hamid
    Dahmardeh-Ghalehno, Asefeh
    Jamialahmadi, Khadijeh
    MOLECULAR BIOLOGY RESEARCH COMMUNICATIONS, 2021, 10 (03) : 109 - 119
  • [42] Ceramide kinase confers tamoxifen resistance in estrogen receptor-positive breast cancer by altering sphingolipid metabolism
    Huang, Cheng
    Su, Liangping
    Chen, Yitian
    Wu, Sangqing
    Sun, Ruipu
    Xu, Qiuping
    Qiu, Xiaoyi
    Yang, Ciqiu
    Kong, Xiangzhan
    Qin, Hongquan
    Zhao, Xinbao
    Jiang, Xue
    Wang, Kun
    Zhu, Yinghua
    Wong, Ping-Pui
    PHARMACOLOGICAL RESEARCH, 2023, 187
  • [43] Obesity, tamoxifen use, and outcomes in women with estrogen receptor-positive early-stage breast cancer
    Dignam, JJ
    Wieand, K
    Johnson, KA
    Fisher, B
    Xu, L
    Mamounas, EP
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (19): : 1467 - 1476
  • [44] Targeted MS Assay Predicting Tamoxifen Resistance in Estrogen Receptor-Positive Breast Cancer Tissues and Sera
    De Marchi, Tommaso
    Kuhn, Erik
    Dekker, Lennard J.
    Stingl, Christoph
    Braakman, Rene B. H.
    Opdam, Mark
    Linn, Sabine C.
    Sweep, Fred C. G. J.
    Span, Paul N.
    Luider, Theo M.
    Foekens, John A.
    Martens, John W. M.
    Carr, Steven A.
    Umar, Arzu
    JOURNAL OF PROTEOME RESEARCH, 2016, 15 (04) : 1230 - 1242
  • [45] Tamoxifen Response at Single-Cell Resolution in Estrogen Receptor-Positive Primary Human Breast Tumors
    Kim, Hyunsoo
    Whitman, Austin A.
    Wisniewska, Kamila
    Kakati, Rasha T.
    Garcia-Recio, Susana
    Calhoun, Benjamin C.
    Franco, Hector L.
    Perou, Charles M.
    Spanheimer, Philip M.
    CLINICAL CANCER RESEARCH, 2023, 29 (23) : 4894 - 4907
  • [46] Mammographic Density Decline, Tamoxifen Response, and Prognosis by Molecular Characteristics of Estrogen Receptor-Positive Breast Cancer
    Abubakar, Mustapha
    Mullooly, Maeve
    Nyante, Sarah
    Pfeiffer, Ruth M.
    Bowles, Erin J. Aiello
    Cora, Renata
    Bodelon, Clara
    Butler, Ebonee
    Butcher, Donna
    Sternberg, Lawrence
    Troester, Melissa A.
    Weinmann, Sheila
    Sherman, Mark
    Glass, Andrew G.
    de Gonzalez, Amy Berrington
    Gierach, Gretchen L.
    JNCI CANCER SPECTRUM, 2022, 6 (03)
  • [47] Tamoxifen resistance alters sensitivity to 5-fluorouracil in a subset of estrogen receptor-positive breast cancer
    Watanabe, Takayuki
    Oba, Takaaki
    Tanimoto, Keiji
    Shibata, Tomohiro
    Kamijo, Shinobu
    Ito, Ken-ichi
    PLOS ONE, 2021, 16 (06):
  • [48] Tamoxifen induces heparanase expression in estrogen receptor - Positive breast cancer
    Cohen, Irit
    Maly, Bella
    Simon, Itamar
    Meirovitz, Amichay
    Pikarsky, Eli
    Zcharia, Eyal
    Peretz, Tamar
    Vlodavsky, Israel
    Elkin, Michael
    CLINICAL CANCER RESEARCH, 2007, 13 (14) : 4069 - 4077
  • [49] Tamoxifen and the Farnesyl Transferase Inhibitor FTI-277 Synergize to Inhibit Growth in Estrogen Receptor-Positive Breast Tumor Cell Lines
    Chad A. Ellis
    Michele D. Vos
    Meredith Wickline
    Christine Riley
    Teresa Vallecorsa
    William G. Telford
    JoAnne Zujewski
    Geoffrey J. Clark
    Breast Cancer Research and Treatment, 2003, 78 : 59 - 67
  • [50] Tamoxifen and the farnesyl transferase inhibitor FTI-277 synergize to inhibit growth in estrogen receptor-positive breast tumor cell lines
    Ellis, CA
    Vos, MD
    Wickline, M
    Riley, C
    Vallecorsa, T
    Telford, WG
    Zujewski, J
    Clark, GJ
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 78 (01) : 59 - 67
12345